Literature DB >> 15575226

[Primary malignant lymphoma of the ureter: a case report].

Hiromitsu Fujisawa1, Hiroshi Takagane, Kenji Shimosegawa, Tsutomu Sakuma.   

Abstract

A 58-year-old man who had right hydronephrosis pointed out by medical checkup visited our hospital. Computed tomography and retrograde pyelography revealed a soft tissue mass in the middle portion of the right ureter. Urine cytology specimen from the right ureter suggested transitional cell carcinoma. Under the diagnosis of right ureteral cancer, we performed right total nephro-ureterectomy, partial cystectomy. The histopathological examination showed non-Hodgkin lymphoma (large B-cell type) of the ureter. Our diagnosis was Clinical Stage IE of the Ann Arbor Classification. The patient received only the first course of systemic chemotherapy (THP-cop), because he suffered severe thrombocytopenia in the course of the chemotherapy. No recurrence was found for 15 months after operation, and at present he is disease-free.

Entities:  

Mesh:

Year:  2004        PMID: 15575226

Source DB:  PubMed          Journal:  Hinyokika Kiyo        ISSN: 0018-1994


  4 in total

1.  Primary Ureteral Lymphoma Presenting with Acute Flank Pain.

Authors:  Christopher Foote; Sean Henderson; Shilpa Reddy; Mindy Horrow; John Leighton; David Cahn; Greg Diorio; Michael Bickell; Phillip Ginsberg; Michael Metro
Journal:  Curr Urol       Date:  2014-08-20

2.  Bilateral primary malignant lymphoma of the ureter.

Authors:  Yasuaki Kubota; Atsushi Kawai; Tomohiro Tsuchiya; Keitaroh Kozima; Shigeaki Yokoi; Takashi Deguchi
Journal:  Int J Clin Oncol       Date:  2007-12-21       Impact factor: 3.402

3.  Ureteric lymphoma as a rare cause of right lower ureteric obstruction.

Authors:  Jayaram Sreenivas; Ashwin Mallya; Vilvapathy Senguttuvan Karthikeyan; Usha Amirtham
Journal:  BMJ Case Rep       Date:  2016-01-29

4.  Ovarian lymphoma and hydronephrosis.

Authors:  Eugenio Volpi; Luca Bernardini; Moira Angeloni; Paolo Gogna; Donatella Intersimone; Franco Fedeli
Journal:  JSLS       Date:  2013 Oct-Dec       Impact factor: 2.172

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.